Brick & Kyle Associates Sells 210 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Brick & Kyle Associates decreased its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 8.8% during the 2nd quarter, Holdings Channel reports. The fund owned 2,167 shares of the financial services provider’s stock after selling 210 shares during the quarter. Brick & Kyle Associates’ holdings in iShares Biotechnology ETF were worth $297,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of the company. Future Financial Wealth Managment LLC bought a new stake in shares of iShares Biotechnology ETF in the first quarter worth about $27,000. Bbjs Financial Advisors LLC acquired a new position in shares of iShares Biotechnology ETF in the 2nd quarter valued at approximately $31,000. Pacifica Partners Inc. increased its stake in iShares Biotechnology ETF by 118.2% during the 1st quarter. Pacifica Partners Inc. now owns 240 shares of the financial services provider’s stock worth $33,000 after purchasing an additional 130 shares in the last quarter. YHB Investment Advisors Inc. acquired a new stake in iShares Biotechnology ETF during the 1st quarter worth approximately $37,000. Finally, Mather Group LLC. bought a new position in iShares Biotechnology ETF in the first quarter valued at approximately $57,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Up 0.5 %

iShares Biotechnology ETF stock opened at $144.90 on Friday. iShares Biotechnology ETF has a twelve month low of $111.83 and a twelve month high of $150.57. The company has a 50 day moving average of $145.70 and a 200-day moving average of $138.83.

iShares Biotechnology ETF Dividend Announcement

The company also recently announced a dividend, which will be paid on Monday, September 30th. Shareholders of record on Wednesday, September 25th will be issued a dividend of $0.2005 per share. The ex-dividend date of this dividend is Wednesday, September 25th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.